Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sim

Showing results (301-310 of 548) with videos related to

Pageof 55
Sort By:
Public Health|December 2, 2021
COVID-19 vaccination acceptability in the UK at the start of the vaccination programme: a nationally representative cross-sectional survey (CoVAccS - wave 2)S M Sherman, J Sim, M Cutts, et al.
Biological Psychiatry|January 24, 2012
β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent mannerPeter T Nguyen, Cullen L Schmid, Kirsten M Raehal, et al.
Journal of Natural Products|August 11, 2011
Sesterterpenes from the tropical sponge Coscinoderma spJaemin Bae, Ju-Eun Jeon, Yeon-Ju Lee, et al.
Kidney International|May 7, 2015
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertensionJohn J Sim, Simran K Bhandari, Jiaxiao Shi, et al.
Journal of Neurochemistry|December 3, 1999
Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brainC S Breivogel, S R Childers, S A Deadwyler, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 6, 2017
Feasibility and acceptability of introducing routine antenatal contraceptive counselling and provision of contraception after delivery: the APPLES pilot evaluationS T Cameron, A Craig, J Sim, et al.
Molecular Pharmacology|March 31, 2006
Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptorSteven W Paugh, Michael P Cassidy, Hengjun He, et al.
Marine Drugs|November 3, 2012
Cyclic Bis-1,3-dialkylpyridiniums from the sponge Haliclona spYoonyeong Lee, Kyoung Hwa Jang, Ju-Eun Jeon, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 14, 2020
Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancerRoss D Dolan, Louise Daly, Wei M J Sim, et al.
Neuropharmacology|August 19, 2008
Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in ratsJenny L Wiley, Seth H Kendler, James J Burston, et al.
Pageof 55

Showing results (301-310 of 548) with videos related to

Sort By:
Pageof 55
Public Health|December 2, 2021
COVID-19 vaccination acceptability in the UK at the start of the vaccination programme: a nationally representative cross-sectional survey (CoVAccS - wave 2)S M Sherman, J Sim, M Cutts, et al.
Biological Psychiatry|January 24, 2012
β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent mannerPeter T Nguyen, Cullen L Schmid, Kirsten M Raehal, et al.
Journal of Natural Products|August 11, 2011
Sesterterpenes from the tropical sponge Coscinoderma spJaemin Bae, Ju-Eun Jeon, Yeon-Ju Lee, et al.
Kidney International|May 7, 2015
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertensionJohn J Sim, Simran K Bhandari, Jiaxiao Shi, et al.
Journal of Neurochemistry|December 3, 1999
Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brainC S Breivogel, S R Childers, S A Deadwyler, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 6, 2017
Feasibility and acceptability of introducing routine antenatal contraceptive counselling and provision of contraception after delivery: the APPLES pilot evaluationS T Cameron, A Craig, J Sim, et al.
Molecular Pharmacology|March 31, 2006
Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptorSteven W Paugh, Michael P Cassidy, Hengjun He, et al.
Marine Drugs|November 3, 2012
Cyclic Bis-1,3-dialkylpyridiniums from the sponge Haliclona spYoonyeong Lee, Kyoung Hwa Jang, Ju-Eun Jeon, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 14, 2020
Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancerRoss D Dolan, Louise Daly, Wei M J Sim, et al.
Neuropharmacology|August 19, 2008
Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in ratsJenny L Wiley, Seth H Kendler, James J Burston, et al.
Pageof 55